NewAmsterdam Pharma Company N.V. (NAMS)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 21.97 |
| Open | 22.06 |
| Bid | 22.41 x 100 |
| Ask | 22.98 x 100 |
| Day's range | 22.06 - 22.99 |
| 52-week range | 5.63 - 26.35 |
| Volume | |
| Avg. volume | 222,750 |
| Market cap | 2.015B |
| Beta (5Y monthly) | 0.02 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
NewAmsterdam Pharma Full Year 2023 Earnings: Revenues Miss Expectations
NewAmsterdam Pharma ( NASDAQ:NAMS ) Full Year 2023 Results Key Financial Results Revenue: US$14.1m (down 87% from FY...
- GuruFocus.com
NewAmsterdam Pharma Co NV (NAMS) Faces Net Loss in 2023 Despite Clinical Progress
Company Advances Clinical Trials and Strengthens Financial Position
- Simply Wall St.
Institutions own 18% of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) shares but private equity firms control 52% of the company
Key Insights NewAmsterdam Pharma's significant private equity firms ownership suggests that the key decisions are...
© 2024 Yahoo. All rights reserved.